Cabergoline
Product Images NDC 83085-003

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 83085-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Skg Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Image001)

Packaging label of Cabergoline Tablets, USP 0.5 mg by SKG Pharma Inc. The label includes a barcode, mentions 'Rx only', and indicates a package size of 8 tablets. It provides storage instructions and warns to keep drugs out of reach of children. The label states the product is made in India and includes a placeholder for a 2D data matrix code with batch and expiration details.*

FDA Label Image

Structutre (Structure001)

Chemical structure diagram of the active ingredient Cabergoline showing its molecular arrangement with labeled atoms and bonds as part of the FDA SPL submission for SKG Pharma Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.